Clincosm LogoSign in Get a demo

SARS-CoV 2

Showing 1 - 25 of 95
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV 2, COVID, ARDS Trial in United States (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or

Terminated
  • SARS-CoV 2
  • +5 more
  • ZYESAMI™ (aviptadil acetate)
  • +2 more
  • Fullerton, California
  • +12 more
Feb 2, 2023

SARS-CoV 2, COVID, ARDS Trial (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo)

Withdrawn
  • SARS-CoV 2
  • +5 more
  • ZYESAMI™ (aviptadil acetate)
  • +2 more
  • (no location specified)
Feb 2, 2023

COVID-19, SARS-CoV 2 Trial in Swansea (Carrageenan nasal and throat spray, Saline nasal and throat spray)

Recruiting
  • COVID-19
  • SARS-CoV 2
  • Carrageenan nasal and throat spray
  • Saline nasal and throat spray
  • Swansea, United Kingdom
    Joint Clinical Research Facility
Oct 7, 2022

Post Covid-19 Respiratory, Dyspnea, SARS-CoV 2 Trial in New York (Respiratory Music Therapy Protocol)

Enrolling by invitation
  • Post Covid-19 Respiratory
  • +2 more
  • Respiratory Music Therapy Protocol
  • New York, New York
  • +1 more
Sep 16, 2022

SARS-COV2 (COVID-19) Persistence After Convalescence

Recruiting
  • COVID-19
  • +2 more
    • New York, New York
      Columbia University Medical Center
    Jul 19, 2022

    Coronavirus Infection, SARS-CoV 2 Trial in Seongnam-si, Seoul (biological, device, other)

    Completed
    • Coronavirus Infection
    • SARS-CoV 2
    • INO-4800
    • +2 more
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +1 more
    Jul 14, 2022

    COVID-19, SARS-CoV 2 Trial in Madison (10% Povidone-iodine nasal decolonization swab plus 0.12% CHG oral rinse)

    Completed
    • COVID-19
    • SARS-CoV 2
    • 10% Povidone-iodine nasal decolonization swab plus 0.12% CHG oral rinse
    • Madison, Wisconsin
      University of Wisconsin-Madison
    Jul 12, 2022

    SARS-CoV 2, COVID-19, Coronavirus Disease 2019 Trial in France (Masitinib, Isoquercetin, Best Supportive Care)

    Recruiting
    • SARS-CoV 2
    • +2 more
    • Aix-en-Provence, France
    • +5 more
    Jun 20, 2022

    COVID-19, Coronavirus, Coronavirus Infections Trial in Detroit (drug, other, diagnostic test)

    Terminated
    Has Results
    • COVID-19
    • +3 more
    • Hydroxychloroquine - Daily Dosing
    • +6 more
    • Detroit, Michigan
      Henry Ford Hospital
    Jun 15, 2022

    SARS-CoV 2 Trial in United States (SARS-CoV-2 convalescent plasma, Plasma from a volunteer donor)

    Active, not recruiting
    • SARS-CoV 2
    • SARS-CoV-2 convalescent plasma
    • Plasma from a volunteer donor
    • Birmingham, Alabama
    • +24 more
    Jun 2, 2022

    Clinical Presentation and Management of COVID-19 in Emergency

    Completed
    • Corona Virus Infection
    • SARS-CoV 2
    • Retrospective data collection
    • Cologne, Germany
      University Hospital of Cologne
    May 24, 2022

    PROSAIC-19 - Prospective Longitudinal Assessment inCOVID-19

    Recruiting
    • COVID-19
    • +3 more
    • Blood tests sputum, nasal lavage and brushing
    • London, United Kingdom
      Royal Brompton & Harefileld NHS Trusts
    May 24, 2022

    Kidney in Coronavirus Disease 2019 Registry

    Recruiting
    • Corona Virus Infection
    • SARS-CoV 2
    • Retrospective data collection
    • Cologne, Germany
      University Hospital of Cologne
    May 23, 2022

    COVID-19, SARS-CoV 2, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in San Francisco (Oral-B Mouth Sore mouthwash, Crest

    Recruiting
    • COVID-19
    • +5 more
    • Oral-B Mouth Sore mouthwash
    • +4 more
    • San Francisco, California
      University Of California, San Francisco
    May 17, 2022

    Enhanced Triage for COVID-19

    Recruiting
    • COVID-19
    • SARS-CoV 2
      • Toronto, Ontario, Canada
        University Health Network
      Apr 7, 2022

      SARS-CoV 2 Trial in Spain (Hyperimmune plasma, Standard of care for SARS-CoV-2 infection)

      Completed
      • SARS-CoV 2
      • Hyperimmune plasma
      • Standard of care for SARS-CoV-2 infection
      • Jerez de la Frontera, Cádiz, Spain
      • +13 more
      Apr 5, 2022

      SARS-CoV 2 Trial in Montréal, Québec (Intramuscular Vaccine)

      Completed
      • SARS-CoV 2
      • Intramuscular Vaccine
      • Montréal, Quebec, Canada
      • +1 more
      Apr 4, 2022

      COVID, SARS-CoV 2, Corona Virus Infection Trial in Antwerp

      Recruiting
      • COVID
      • +4 more
        • Antwerp, Belgium
          Universitairy hospital of Antwerp
        Apr 4, 2022

        COVID-19, Therapeutic Vaccine, BCG Trial in Campinas (BCG, Placebo)

        Active, not recruiting
        • COVID-19
        • +4 more
        • BCG
        • Placebo
        • Campinas, SP, Brazil
          Hospital das Clínicas Unicamp
        Mar 23, 2022

        COVID-19 Infection and Machine Learning Using Artificial

        Recruiting
        • COVID-19
        • +2 more
          • Ipswich, United Kingdom
            East Suffolk and North Essex NHS Foundation Trust
          Mar 21, 2022

          COVID-19; Isolation of Neutralizing Antibodies for Therapeutics

          Active, not recruiting
          • SARS-CoV 2
          • Blood sampling
          • Grenoble, France
            UniversityGrenobleHospital
          Mar 24, 2022

          Covid-19, Nosocomial Infection, Coronavirus Trial in London (Use of virus (Covid-19) genome sequence report to inform infection

          Completed
          • Covid-19
          • +4 more
          • Use of virus (Covid-19) genome sequence report to inform infection prevention control procedures
          • London, United Kingdom
            University College London Hospitals NHS Foundation Trust
          Feb 16, 2022

          In-vitro Diagnostic Test to Predict COVID-19 Mortality and

          Recruiting
          • SARS-CoV 2
          • +5 more
          • CAG length <22
          • CAG length >=22
          • Madrid, Spain
            Hospital Universitario Ramon y Cajal
          Feb 17, 2022

          SARS-CoV 2, COVID-19 Trial in Manama (5-ALA-Phosphate + SFC (5-ALA + SFC))

          Completed
          • SARS-CoV 2
          • COVID-19
          • 5-ALA-Phosphate + SFC (5-ALA + SFC)
          • Manama, Bahrain
          • +1 more
          Feb 8, 2022

          Seroprevalence of SARS-CoV-2 Antibodies and Development of

          Recruiting
          • SARS-CoV 2
          • COVID-19
          • COVID-19 Antibody testing
          • Zurich, Switzerland
            Epidemiology, Biostatistics and Prevention Institute (EBPI), Uni
          Dec 9, 2021